RxDoctor Payments Data

Tana Frumento, PA

Physician Assistant · Phoenix, AZNPI 1972644532

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $15,669 of the $24,564 with a category attached, or 63.8%. It is spread thinly across 34 manufacturers, the largest accounting for just 22.7%. Reporting peaked in 2024 at $7,458 and has fallen 52.2% since, to $3,562 in 2025. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,564in general payments, 2019–2025

Across 838 payments — averaging $29.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$6K
  • AbbVie$3K
  • Johnson & Johnson$2K
  • E.r. Squibb & Sons, L.L.C.$2K
  • Amgen$2K
  • LEO Pharma Inc.$2K
  • plus $9K from 28 others

What the payments were for

  • Consulting fees$7,51431%
  • Speaking & faculty fees$8003%
  • Food & beverage$15,66964%
  • Education$5812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,564 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$84,700
Medicare patients
348
Services billed
3,167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa21$468,516
Cosentyx Unoready PenSecukinumab25$291,192
Humira(Cf) PenAdalimumab16$174,770
Dupixent PenDupilumab33$143,000
Dupixent SyringeDupilumab24$95,413
Clobetasol Propionate288$13,569
Ketoconazole334$4,608
Tretinoin67$3,840
Doxycycline Hyclate127$3,414
Pimecrolimus21$3,411
Tacrolimus27$2,883
Triamcinolone Acetonide158$2,334
Clindamycin Phosphate71$1,955
Fluocinolone Acetonide19$1,592
Metronidazole20$1,195

Paid to pharmacies, not to this prescriber.

Other physician assistant in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →